The association of serum uric acid levels with outcomes following percutaneous coronary intervention

Journal of Interventional Cardiology

Volumn 23, Issue 3, 2010, Pages 277-283

  Spoon, Daniel B ^a   Lerman, Amir ^a   Rule, Andrew D ^a   Prasad, Abhiram ^a   Lennon, Ryan J ^a   Holmes, David R ^a   Rihal, Charanjit S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ADVERSE OUTCOME; AGED; ARTICLE; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERURICEMIA; INFORMATION RETRIEVAL; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; FEMALE; HUMANS; HYPERURICEMIA; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS AS TOPIC; TREATMENT OUTCOME; URIC ACID;

EID: 77953196992     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00555.x     Document Type: Article

References (18)

1. Mohamed FA. On Bright's disease, and its essential symptoms. Lancet 1879 1 : 399 401.
2. Haig A. On uric acid and arterial tension. BMJ 1889 1 : 288 291.
3. Ioachimescu AG, Brennan DM, Hoar BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease. Arthritis Rheum 2008 58 : 623 630.
4. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000 283 : 2404 2410.
5. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med 2004 164 : 1546 1551.
6. Dunkelgrun M, Welten GM, Toei D, et al. Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery. Am J Cardiol 2008 102 : 797 801.
7. Kang DH, Park SK, Lee IK, et al. Uric acid induced C-reactive protein (CRP) expression: Implication on cell proliferation and nitric oxide production in human vascular cells. J Am Soc Nephrol 2005 16 : 3553 3562.
8. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol 2002 282 : F991 F997.
9. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005 67 : 1739 1742.
10. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003 41 : 1183 1190.
11. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002 2 : 126 130.
12. Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am J Med 2005 118 : 816 826.
13. George J, Carr E, Davies J, et al. Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006 114 : 2508 2516.
14. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. J Semin Nephrol 2004 25 : 39 42.
15. Maples KR, Mason RP. Free radical metabolite of uric acid. J Biol Chem 1988 263 : 1709 1712.
16. Santos CX, Anjos EI, Augusto O. Uric acid oxidation by peroxynitrite: Multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 1999 372 : 285 294.
17. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991 266 : 8604 8608.
18. Kang DH, Han L, Ouyang X, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005 25 : 425 433.